Anakinra in mutation-negative CINCA syndrome

Clinical Rheumatology

Volumn 26, Issue 4, 2007, Pages 576-577

  Callejas, José Luis ^a   Oliver, Javier ^b   Martín, Javier ^b   Ortego, Norberto ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

CIAS1 protein; Human; Interleukin 1 receptor antagonist protein

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CIAS1 PROTEIN; CORTICOSTEROID; INTERLEUKIN 1; PROTEIN DERIVATIVE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ARTHROPATHY; ARTICLE; BRAIN ATROPHY; CASE REPORT; CELL INFILTRATION; CHONDROPATHY; CINCA SYNDROME; CLINICAL FEATURE; DRUG RESPONSE; FEVER; GROWTH RETARDATION; HEPATOSPLENOMEGALY; HUMAN; HYDROCEPHALUS; INFLAMMATORY DISEASE; LYMPHADENOPATHY; MALE; MENINGITIS; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; ONSET AGE; OSSIFICATION; PERCEPTION DEAFNESS; POLYMERASE CHAIN REACTION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RASH; UVEITIS;

ADOLESCENT; CENTRAL NERVOUS SYSTEM DISEASES; DERMATITIS; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1ALPHA; JOINT DISEASES; MALE; RECOMBINANT PROTEINS; SYNDROME;

EID: 33847682291     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0168-z     Document Type: Article

References (10)

1. Prieur AM, Griscelli C, Lampert F, Truckenbrodt H, Guggenheim MA, Lovell DJ et al (1987) A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol 66:57-68
2. De Boeck H, Scheerlinck T, Otten J (2000) The CINCA syndrome: A rare cause of chronic arthritis and multisystem inflammatory disorders. Acta Orthop Belg 66:433-437
3. Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, Cortis E et al (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71:198-203
4. Hawkins PH, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50:607-612
5. Granel B, Serratrice J, Disdier P, Weiller PJ (2005) Dramatic improvement with anakinra in a case of chronic infantile neurological cutaneous and articular (CINCA) syndrome. Rheumatology 44:689-690
6. Frenkel J, Wulffraat NM, Kuis W (2004) Anakinra in mutation-negative NOMID/CINCA syndrome. Arthritis Rheum 50(11):3738-3739
7. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD (2001) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29:301-305
8. Tschopp J, Martinon F, Burns K (2003) NALPs: A novel protein family involved in inflammation. Nat Rev Mol Cell Biol 4:95-104
9. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL et al (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340
10. Ramos E, Arostegui JI, Campuzano S, Rius J, Bousono C, Yague J (2005) Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS). Rheumatology (Oxford) 44:1072-1073